Wautlet, Cynthie K published the artcileHypertensive Crisis in Pregnancy., Related Products of pyridine-derivatives, the main research area is Antihypertensive treatment; Hypertension; Hypertensive crisis; Preeclampsia; Pregnancy.
Severe hypertension in pregnancy is a medical emergency, defined as systolic blood pressure (BP) â?160Â mm Hg and/or diastolic BP â?110Â mm Hg taken 15Â minutes to 4 or more hours apart. Outside pregnancy, acute severe hypertension (HTN) is defined as a BP greater than 180/110 to 120 reproducible on 2 occasions. The lower threshold for severe HTN in pregnancy reflects the increased risk for adverse outcomes, particularly maternal stroke and death, and may be a source of under-recognition and treatment delay, particularly in nonobstetrical health care settings. Once a severe hypertension episode is recognized, antihypertensive therapy should be initiated as soon as feasibly possible, at least within 30 to 60Â minutes. Intravenous (IV) labetalol, hydralazine, and oral immediate-release nifedipine are all recommended first-line agents and should be administered according to available institutional protocols and based on provider knowledge and familiarity.
Obstetrics and gynecology clinics of North America published new progress about Antihypertensive treatment; Hypertension; Hypertensive crisis; Preeclampsia; Pregnancy. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Related Products of pyridine-derivatives.